Age of menopause among women who remain premenopausal following treatment for early breast cancer: Long-term results from International Breast Cancer Study Group Trials V and VI

European Journal of Cancer

Volumn 43, Issue 11, 2007, Pages 1646-1653

  Partridge, Ann ^a,b,c   Gelber, Shari ^a   Gelber, Richard D ^a,c,d   Castiglione Gertsch, Monica ^e   Goldhirsch, Aron ^f,g   Winer, Eric ^a,b,c  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e IBCSG Coordinating Center   (Switzerland)

^f EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^g ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

Author keywords

Breast cancer; Fertility; Premature menopause; Young women

Indexed keywords

CYCLOPHOSPHAMIDE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE; PREDNISONE;

ADULT; AMENORRHEA; ARTICLE; BREAST CANCER; CLINICAL TRIAL; DATA ANALYSIS; EARLY MENOPAUSE; FACTORIAL DESIGN; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PREMENOPAUSE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

ADULT; AGE FACTORS; AMENORRHEA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COHORT STUDIES; CYCLOPHOSPHAMIDE; FEMALE; FLUOROURACIL; HUMANS; MENOPAUSE; METHOTREXATE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS;

EID: 34447272269     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2007.04.006     Document Type: Article

References (35)

1. Minton S.E., and Munster P.N. Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer. Cancer Control 9 6 (2002) 466-472
2. Burstein H.J., and Winer E.P. Primary care for survivors of breast cancer. N Engl J Med 343 15 (2000) 1086-1094
3. Petrek J.A., Naughton M.J., Case L.D., et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 24 7 (2006) 1045-1051
4. Lee S.J., Schover L.R., Partridge A.H., et al. American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients. J Clin Oncol 24 (2006) 2917-2931
5. Byrne J., Fears T.R., Gail M.H., et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 166 3 (1992) 788-793
6. Chiarelli A.M., Marrett L.D., and Darlington G. Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964-1988 in Ontario Canada. Am J Epidemiol 150 3 (1999) 245-254
7. Sklar C.A., Mertens A.C., Mitby P., et al. Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 98 13 (2006) 890-896
8. Valagussa P., De Candis D., Antonelli G., and Bonadonna G. Women's health perception and breast cancer: issues of fertility, hormone substitution, and cancer prevention. Recent Results Cancer Res 140 (1996) 277-283
9. Partridge A.H., Gelber S., Peppercorn J., et al. Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol 22 20 (2004) 4174-4183
10. Molina J.R., Barton D.L., and Loprinzi C.L. Chemotherapy-induced ovarian failure: manifestations and management. Drug Saf 28 5 (2005) 401-416
11. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer.The Ludwig Breast Cancer Study Group. N Engl J Med 1989;320(8):491-6.
12. Combination adjuvant chemotherapy for node-positive breast cancer. Inadequacy of a single perioperative cycle. The Ludwig Breast Cancer Study Group. N Engl J Med 1988;319(11):677-83.
13. Duration and reintroduction of adjuvant chemotherapy for node-positive premenopausal breast cancer patients. International Breast Cancer Study Group. J Clin Oncol 1996;14(6):1885-94.
14. Gray R.J. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16 (1988) 1141-1154
15. Goodwin P.J., Ennis M., Pritchard K.I., Trudeau M., and Hood N. Risk of menopause during the first year after breast cancer diagnosis. J Clin Oncol 17 8 (1999) 2365-2370
16. Burstein H.J., and Winer E.P. Reproductive issues. In: Harris J.R. (Ed). Diseases of the breast. 2nd ed. (2000), Lippincott, Philadelphia 1051-1059
17. Hortobagyi G.N., Buzdar A.U., Marcus C.E., and Smith T.L. Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute. NCI Monogr 1 (1986) 105-109
18. Willett W., Stampfer M.J., Bain C., et al. Cigarette smoking, relative weight, and menopause. Am J Epidemiol 117 6 (1983) 651-658
19. Stanford J.L., Hartge P., Brinton L.A., Hoover R.N., and Brookmeyer R. Factors influencing the age at natural menopause. J Chronic Dis 40 11 (1987) 995-1002
20. Brambilla D.J., and McKinlay S.M. A prospective study of factors affecting age at menopause. J Clin Epidemiol 42 11 (1989) 1031-1039
21. Luoto R., Kaprio J., and Uutela A. Age at natural menopause and sociodemographic status in Finland. Am J Epidemiol 139 1 (1994) 64-76
22. Gold E.B., Bromberger J., Crawford S., et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am J Epidemiol 153 9 (2001) 865-874
23. Lawlor D.A., Ebrahim S., and Smith G.D. The association of socio-economic position across the life course and age at menopause: the British Women's Heart and Health Study. Bjog 110 12 (2003) 1078-1087
24. Pagani O., O'Neill A., Castiglione M., et al. Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI. Eur J Cancer 34 5 (1998) 632-640
25. Goldhirsch A., Gelber R.D., and Castiglione M. The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients The International Breast Cancer Study Group. Ann Oncol 1 3 (1990) 183-188
26. Davidson N.E. Ovarian ablation as adjuvant therapy for breast cancer. J Natl Cancer Inst Monogr 30 (2001) 67-71
27. Oktay K., Oktem O., Reh A., and Vahdat L. Measuring the impact of chemotherapy on fertility in women with breast cancer. J Clin Oncol 24 24 (2006) 4044-4046
28. Ganz P.A., Coscarelli A., Fred C., Kahn B., Polinsky M.L., and Petersen L. Breast cancer survivors: psychosocial concerns and quality of life. Breast Cancer Res Treat 38 2 (1996) 183-199
29. Ganz P.A., Rowland J.H., Desmond K., Meyerowitz B.E., and Wyatt G.E. Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol 16 2 (1998) 501-514
30. Meyerowitz B.E., Desmond K.A., Rowland J.H., Wyatt G.E., and Ganz P.A. Sexuality following breast cancer. J Sex Marital Ther 25 3 (1999) 237-250
31. Kreuser E.D., Felsenberg D., Behles C., et al. Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease. Ann Oncol 3 Suppl. 4 (1992) 105-110
32. Bruning P.F., Pit M.J., de Jong-Bakker M., van den Ende A., Hart A., and van Enk A. Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer. Br J Cancer 61 2 (1990) 308-310
33. Park K.H., and Song C.H. Bone mineral density in premenopausal anovulatory women. J Obstet Gynaecol 21 1 (1995) 89-97
34. Howell S.J., Berger G., Adams J.E., and Shalet S.M. Bone mineral density in women with cytotoxic-induced ovarian failure. Clin Endocrinol (Oxf) 49 3 (1998) 397-402
35. Ganz P.A., Greendale G.A., Petersen L., Kahn B., and Bower J.E. Breast cancer in younger women: reproductive and late health effects of treatment. J Clin Oncol 21 22 (2003) 4184-4193